Evonetix unveils new branding to align with its vision for gene-length DNA synthesis Post author: Post published:October 2, 2023 Post category:uncategorized EVONETIX LTD (‘Evonetix’) today announces the introduction of new branding. You Might Also Like Breakthrough in tuberculosis treatment: TB-PRACTECAL trial reveals efficacy of new oral regimen November 20, 2023 New outreach campaign promotes collaboration between oral health providers and family physicians October 10, 2023 Micropore appoints new CEO August 30, 2024
Breakthrough in tuberculosis treatment: TB-PRACTECAL trial reveals efficacy of new oral regimen November 20, 2023
New outreach campaign promotes collaboration between oral health providers and family physicians October 10, 2023